Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India[1]
- Market Cap ₹ 4,530 Cr.
- Current Price ₹ 1,042
- High / Low ₹ 1,258 / 970
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE -0.18 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.52.6 Cr.
- Company has high debtors of 153 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| 105 | 137 | 178 | |
| 137 | 191 | 222 | |
| Operating Profit | -32 | -54 | -44 |
| OPM % | -30% | -39% | -25% |
| 23 | 27 | 53 | |
| Interest | 2 | 5 | 11 |
| Depreciation | 7 | 9 | 10 |
| Profit before tax | -18 | -41 | -12 |
| Tax % | 0% | 0% | 0% |
| -18 | -41 | -12 | |
| EPS in Rs | -1,811.38 | -106.10 | -30.31 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | 0 | 4 | 4 |
| Reserves | -31 | -72 | -84 |
| Preference Capital | 517 | 619 | 664 |
| 23 | 56 | 112 | |
| 540 | 666 | 732 | |
| Total Liabilities | 533 | 654 | 764 |
| 50 | 51 | 41 | |
| CWIP | 2 | 0 | 0 |
| Investments | 39 | 39 | 41 |
| 442 | 563 | 682 | |
| Total Assets | 533 | 654 | 764 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| -68 | -45 | -57 | |
| -7 | -69 | -58 | |
| 76 | 127 | 91 | |
| Net Cash Flow | 0 | 14 | -24 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Debtor Days | 107 | 139 | 153 |
| Inventory Days | 177 | 103 | 68 |
| Days Payable | 48 | 99 | 132 |
| Cash Conversion Cycle | 236 | 143 | 89 |
| Working Capital Days | 1,210 | 1,123 | 1,086 |
| ROCE % | -6% | -0% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
6 May - Of Entero Healthcare Solutions Limited ("Company") has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir …
- Board Meeting Outcome for Outcome Of Board Meeting Held On May 06, 2024 6 May
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 3 May
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 3 May
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 25 Apr
Concalls
-
Mar 2024Transcript PPT
Leading Healthcare Product Disributor[1] The company is among the top three healthcare distributors in India in terms of revenue. Further, it achieved the fastest scale-up of operations among healthcare product distributors in India between FY19 - FY22.